z-logo
open-access-imgOpen Access
Safety of lamivudine treatment for chronic hepatitis B in early pregnancy
Author(s) -
Wei Yi
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i45.6645
Subject(s) - medicine , lamivudine , pregnancy , obstetrics , hepatitis b virus , adverse effect , abortion , postpartum period , hepatitis b , therapeutic abortion , pediatrics , immunology , virus , biology , genetics
To evaluate the safety of lamivudine (LAM) treatment for chronic hepatitis B in early pregnancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom